Isotretinoin doxycycline — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Raised intracranial pressure risk
This scenario assesses Isotretinoin doxycycline in a UK pharmacy practice context. Isotretinoin with tetracyclines increases risk of benign intracranial hypertension. The best answer is Raised intracranial pressure risk because it addresses the principal clinical, legal or safety issue before routine supply. The other options are less appropriate because they either miss the key risk, delay necessary review, or would not meet expected BNF, NICE, MEP, MHRA or GPhC practice standards.
Reference: BNF